VAH vs VA in Newly Diagnosed Elderly AML

NCT07469046 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

308

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia (AML)
Elderly Patients (60-75 Years)

Interventions

DRUG: Venetoclax
DRUG: Azacitidine
DRUG: Homoharringtonine

Sponsor

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine